Item 8.01. Other Events.
On March 16, 2020, Seelos Therapeutics, Inc. (the "Company") issued a press
release announcing the closing of its previously announced underwritten public
offering of shares of its common stock. In the offering, the Company sold an
aggregate of 7,500,000 shares of its common stock at a public offering price of
$0.60 per share. A copy of the press release is attached as Exhibit 99.1 to this
Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Number Description
99.1 Press Release, dated March 16, 2020.
* * *
2
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses